Completed

Conventional Versus Laparoscopic-Assisted Surgery in Colorectal Cancer

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

conventional surgery

+ laparoscopic surgery

Procedure
Who is being recruted

Colonic Diseases+10

+ Digestive System Diseases

+ Digestive System Neoplasms

Over 18 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: July 1996
See protocol details

Summary

Principal SponsorMedical Research Council
Last updated: December 4, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: July 1, 1996

Actual date on which the first participant was enrolled.

OBJECTIVES: Determine whether longitudinal and circumferential resection margins and lymphatic clearances obtained during laparoscopic surgery are different from those obtained with conventional open surgery in patients with colorectal cancer. Compare the patterns of loco-regional or distant metastatic spread after these two surgical methods in these patients. Compare the morbidity and mortality rates in these patients after these two surgical methods, particularly in terms of the technical or thromboembolic complications that may develop as a consequence of prolonged pneumoperitoneum. Compare the disease-free or overall survival of these patients after these two operative procedures. Determine, in those patients in whom laparoscopic surgery fails, which investigatory modalities are appropriate for providing pre-operative indications that a patient is an inappropriate candidate for laparoscopic dissection. Compare the differences in quality of life between the two operative procedures, particularly in patients with advanced disease. OUTLINE: This is a randomized, multicenter study. Patients undergo laparoscopic surgery or conventional open surgery. Patients are followed at 1 and 3 months following surgery, then every 3 months for the first year, every 4 months for the second year, and then every 6 months thereafter. PROJECTED ACCRUAL: Approximately 1,200 patients will be accrued for this study within 5 years.

NCT00003354
Principal SponsorMedical Research Council
Last updated: December 4, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

1200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Colonic DiseasesDigestive System DiseasesDigestive System NeoplasmsGastrointestinal DiseasesGastrointestinal NeoplasmsIntestinal DiseasesIntestinal NeoplasmsNeoplasmsNeoplasms by SiteRectal DiseasesColonic NeoplasmsRectal NeoplasmsColorectal Neoplasms

Criteria

DISEASE CHARACTERISTICS: Histologically confirmed colorectal cancer Must be suitable for elective surgical resection by right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection or abdomino-perineal resection No adenocarcinoma of the transverse colon No synchronous multiple adenocarcinomas PATIENT CHARACTERISTICS: Age: 18 and over Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Pulmonary: No contraindication to pneumoperitoneum such as severe cardio-respiratory disease Other: No acute intestinal obstruction No prior malignancy within the past 5 years, except basal cell carcinoma, carcinoma in situ of the cervix, or prostate cancer Not pregnant No gastrointestinal disease that requires surgical intervention, e.g., Crohn's disease, chronic ulcerative disease, familial polyposis PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Adjuvant chemotherapy allowed Endocrine therapy: Not specified Radiotherapy: Preoperative radiotherapy must be administered before randomization into this trial Adjuvant radiotherapy allowed Surgery: See Disease Characteristics

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 13 locations

Saxon Clinic

Bucks, United KingdomOpen Saxon Clinic in Google Maps

Castle Hill Hospital

Cottingham, United Kingdom

Leeds General Infirmary at Leeds Teaching Hospital NHS Trust

Leeds, United Kingdom

Leeds Cancer Centre at St. James's University Hospital

Leeds, United Kingdom
Completed13 Study Centers